Emergent Biosolutions, Inc.

Historical 13F Holders

Symbol
EBS
CUSIP
29089Q105
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 29089Q105 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 9.0% 7/28/2026
Event 6/30/2026
American Century Investment Management, Inc. 13G
5.4% 8/14/2026
Event 6/30/2026
Dimensional Fund Advisors LP 13G 5.3% 4/9/2026
Event 3/31/2026
State Street Corp 13G 5.1% 2/9/2026
Event 12/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Vanguard Capital Management LLC 13G/A 4.9% 7/31/2026
Event 6/30/2026
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 57 7.95 M $52.5 M
2026 Q2 197 44.6 M $375 M
2026 Q1 192 43.4 M $361 M
2025 Q4 184 43.5 M $538 M
2025 Q3 171 41.7 M $353 M
2025 Q2 163 40.1 M $244 M
2025 Q1 163 36.2 M $176 M
2024 Q4 158 34.7 M $332 M
2024 Q3 142 31.7 M $264 M
2024 Q2 144 32.3 M $220 M
2024 Q1 125 38.8 M $98.4 M
2023 Q4 136 42.9 M $103 M
2023 Q3 164 41.3 M $141 M
2023 Q2 183 45.7 M $337 M
2023 Q1 193 45.0 M $466 M
2022 Q4 200 52.1 M $615 M
2022 Q3 215 40.7 M $855 M
2022 Q2 236 41.2 M $1.28 B
2022 Q1 256 42.1 M $1.73 B
2021 Q4 255 42.9 M $1.87 B
2021 Q3 278 44.5 M $2.23 B
2021 Q2 290 44.8 M $2.82 B
2021 Q1 342 44.6 M $4.14 B
2020 Q4 354 45.9 M $4.11 B
2020 Q3 359 43.2 M $4.47 B
2020 Q2 300 53.8 M $4.21 B
2020 Q1 263 45.4 M $2.62 B
2019 Q4 236 45.6 M $2.46 B
2019 Q3 244 45.0 M $2.35 B
2019 Q2 233 46.0 M $2.22 B
2019 Q1 273 45.3 M $2.29 B
2018 Q4 299 44.2 M $2.62 B
2018 Q3 276 43.8 M $2.89 B
2018 Q2 264 42.8 M $2.16 B
2018 Q1 273 42.6 M $2.23 B
2017 Q4 239 40.4 M $1.88 B
2017 Q3 200 37.1 M $1.50 B
2017 Q2 183 35.6 M $1.20 B
2017 Q1 178 35.7 M $1.04 B
2016 Q4 211 35.9 M $1.18 B
2016 Q3 206 35.9 M $1.13 B
2016 Q2 226 36.2 M $1.02 B
2016 Q1 217 33.7 M $1.23 B
2015 Q4 207 32.8 M $1.31 B
2015 Q3 199 32.9 M $952 M
2015 Q2 184 31.0 M $1.02 B
2015 Q1 174 30.4 M $874 M
2014 Q4 168 30.0 M $816 M
2014 Q3 162 29.9 M $638 M
2014 Q2 159 34.6 M $776 M
2014 Q1 167 28.8 M $729 M